Morning Consult: We Need New Ways to Finance Life Saving Gene Therapies ByProf. Joseph Fuhr April 15, 2019February 28, 2024
Center Maryland: Lawmakers in Annapolis Should Demand Greater Transparency from PBMs ByKrisztina Pusok March 6, 2019June 16, 2022
Latest ConsumerGram: Lowering Drug Prices in Maryland Means Bringing Transparency to PBMs ByKrisztina Pusok March 4, 2019
The Hill: Life-saving gene therapies are here — we need to get them to patients ByLiam Sigaud February 20, 2019
Regulatory Uncertainty and Industry Practices Force Consumers to Overpay on Biologics ByAlan Daley February 19, 2019
Real Clear Health: Consumers Deserve More Transparency from High Drug Prices BySteve Pociask February 14, 2019
Novel Financing Approaches are Needed to Capitalize on Life-Saving Gene Therapies Byeditor February 12, 2019February 11, 2019
